C

Curaleaf

Cannabis cultivation, processing, and retailing

Quality Assurance Manager

Full-TimeUpdated on 10/23/2026
$97k - $108k
Senior
Bachelor's, Master's
Hammonton, NJ, USA
In PersonTravel up to 50%.
Manufacturing Quality & TestValidation, Compliance & Quality Systems
No H1B Sponsorship

About the job

Requirements
  • A relevant Bachelor's and Master's degree in Science, Education, Chemistry, Microbiology, Engineering, Technical, Management, Business, Biology, or Technology.
  • At least 7 years of experience in a Quality Management position within the cannabis, food, pharmaceutical, or nutraceutical industry.
  • Previous supervision of a Quality Control/Quality Assurance department and staff.
  • Previous experience developing or managing training programs.
  • Deep understanding of Food Safety and Quality Management Systems.
  • Understanding of Quality Assurance key performance indicators.
  • Experience managing regulatory and customer visits and/or audits.
  • Experience managing Quality using electronic Quality Management Systems and/or Laboratory Information Management Systems.
  • Ability to apply sound technical and business principles and practices to project and change management processes.
Responsibilities
  • Assist in developing, implementing, managing, and tracking the Quality Management System program, including systems, standards, procedures, measures, and tools to assure product safety, quality, facility sanitation, and compliance with applicable certification and regulatory requirements.
  • Provide guidance and subject matter expertise on Quality Assurance issues, standards, program updates, and process changes to assist internal and external parties with compliance or audit inquiries.
  • Support and comply with quality management systems, continuous improvement programs, product safety plans, employee safety, preventative maintenance programs, and regulations.
  • Follow the company project management process to ensure national quality and product safety requirements and objectives are met.
  • Lead cross-functional project teams and sub-teams developing and implementing new Quality Assurance programs and procedure improvements.
  • Collaborate cross-functionally and globally to align Quality Assurance programs across the company and represent national quality assurance on company-wide cross-functional teams.
  • Manage the quality function by providing leadership and guidance for site operations and quality team members through coaching, training, and counseling.
  • Develop and manage the training program to ensure uniform interpretation and application of standards and procedures for cultivation, manufacturing, sanitation, pest control, and disposition of ingredients or finished products.
  • Manage and analyze national quality metrics, customer feedback, and emerging product trends.
  • Support root cause analysis investigations related to materials and product cultivation, manufacturing, and distribution.
  • Assist in monitoring testing results for raw materials, in-process products, and finished products.
  • Support the transition from research and development to commercial manufacturing.
  • Ensure local sites obtain and maintain applicable certification.
  • Coordinate audit schedules and conduct internal audits, external audits, and vendor qualifications.
  • Lead the national quality assurance and product safety program and related regulatory, certifying body, and customer inspections and/or audits.
  • Stay up to date and build expertise in product safety best practices, public health regulations, and industry best practices.
  • Travel up to 50%.
Desired Qualifications
  • ASQ Certified Quality Auditor, CSQ, HACCP, or SQF Practitioner certifications are preferred but not required.

About the company

Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Stamford, Connecticut

Founded

2010

Get referred to Curaleaf

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue reached $340.1 million, up 10%, with $12.5 million net income.
  • September 2026 Aurora bid targets Germany's medical cannabis market and four 20 Pharma distribution.
  • Curaleaf's Boston opening and Florida expansions add stores, patients, and brand shelf space now.

What critics are saying

  • Curaleaf carried $611.5 million debt against $107 million cash on June 30, 2026.
  • Aurora's board can stall Curaleaf's $4 hostile bid until the December 1, 2026 deadline.
  • Federal illegality keeps Curaleaf exposed to appeals, contract fights, and banking fragility across jurisdictions.

What makes Curaleaf unique

  • Curaleaf spans U.S. dispensaries and EU-GMP manufacturing across Germany, Spain, Portugal, and Canada.
  • On September 2026, Curaleaf became Spain's first standardized medicinal cannabis registrar under Royal Decree 903/2025.
  • Florida remains Curaleaf's scale moat: 77 dispensaries statewide and 178 nationwide on September 4, 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Parental Leave
  • 401(k) Retirement Plan
  • Life Insurance
  • Disability Insurance

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
Sep 15th, 2026
Curaleaf urges Aurora shareholders to accept 45% premium takeover offer

Curaleaf Holdings has issued a letter urging Aurora Cannabis shareholders to accept its takeover offer, which represents a 45% premium over Aurora's 30-day volume weighted average price. The acquisition would create a combined company operating across 17 countries with US$1.5 billion in last twelve-month revenue and nearly US$350 million of adjusted EBITDA. Curaleaf Chairman and CEO Boris Jordan framed the decision starkly, describing Aurora as "a shrinking business that is burning cash and getting less profitable by the day." The company expects at least US$40 million in annual cost synergies from the combination. Aurora has refused to engage with Curaleaf's proposal. Jordan announced a live shareholder Q&A session scheduled for 17 September to discuss the offer directly with Aurora investors.

Yahoo Finance
Sep 2nd, 2026
Curaleaf opens Boston dispensary near Downtown Crossing with expanded retail space

Curaleaf Holdings has opened a new cannabis dispensary in downtown Boston at 21 Milk St., near Downtown Crossing. The location opened on 4 September, offering patients expanded retail space and a broader selection of products. The dispensary will stock Curaleaf's portfolio of cannabis brands, including Dark Heart, Select, FIND, Anthem and Grassroots. Knowledgeable staff will assist customers in selecting products suited to their needs. A grand opening celebration is scheduled for 8 September, featuring in-store promotions, a Meet the Grower event, and brand activations. The store operates from 09:00 to 20:00 Monday through Saturday, and 09:00 to 18:00 on Sunday. The opening follows the closure of Curaleaf's former Provincetown dispensary.

Yahoo Finance
Aug 18th, 2026
Curaleaf launches $4 hostile bid for Aurora Cannabis to access EU medical market

Curaleaf has formally launched its hostile takeover bid for Aurora Cannabis, offering $4 per share directly to shareholders. The offer represents a 45% premium on Aurora's 30-day average share price from 10 August, before Curaleaf announced its intentions. The proposed deal would create a combined company with a $3 billion market cap. Curaleaf projects approximately $40 million in annual cost synergies from the merger. The acquisition aims to give Curaleaf access to EU medical cannabis export markets, particularly Germany. Aurora possesses EU-GMP cultivation capacity that meets strict German import standards. Federal restrictions make direct cannabis exports challenging for US firms like Curaleaf. Curaleaf CEO Boris Jordan said initial friendly discussions with Aurora CEO Miguel Martin earlier this summer stalled, prompting the direct shareholder approach. Aurora's board has formed a special committee to review the offer.

PR Newswire
Aug 5th, 2026
Curaleaf reports $340M Q2 revenue with 10% growth and $12M net income

Curaleaf Holdings reported second quarter 2026 revenue of $340 million, representing 10% year-over-year growth driven by domestic and international segments that grew 7% and 26%, respectively. International revenue reached $51 million. The cannabis company posted net income of $12 million and adjusted EBITDA of $70 million, reflecting a 21% margin. Gross profit margin stood at 50%. Chairman and CEO Boris Jordan said the results demonstrate the company's "Built for Growth" strategy is gaining traction. He noted this marks the second consecutive quarter of domestic year-over-year growth. Curaleaf ended the quarter with $107 million in cash and $611.5 million in outstanding debt. The company invested $32.9 million in capital expenditures during the six-month period, focused on facility upgrades and automation.

PR Newswire
Jul 29th, 2026
Curaleaf opens 75th Florida dispensary, expanding US footprint to 167 locations

Curaleaf Holdings has opened its 75th dispensary in Florida, located in Boynton Beach. The cannabis retailer now operates 167 locations nationwide, with Florida representing nearly half of its retail footprint. The new store at 3575 W. Boynton Beach Boulevard is the company's sixth Florida opening this year. It offers medical cannabis products including Anthem pre-rolls, Dark Heart ultra-premium flower, and Select vaping products. Boris Jordan, chairman and CEO, said the opening reinforces Curaleaf's commitment to expanding access to cannabis products across Florida. A grand opening celebration is scheduled for 31 July and 1 August, featuring special promotions and giveaways. The dispensary operates 9:00 to 20:30 Monday through Saturday, and 10:00 to 18:00 on Sunday.